Document:

<PAGE>

                                                                   EXHIBIT 10.25

                                 ENDOCARE, INC.
                          2002 SUPPLEMENTAL STOCK PLAN

      1. PURPOSES OF THE PLAN. The purposes of this Stock Plan are to:

            (a) Attract and retain the best available personnel for positions of
substantial responsibility;

            (b) Provide additional incentives to Employees and Consultants; and

            (c) Promote the success of the Company's business.

            Options granted under the Plan shall be Nonstatutory Stock Options.

      2. DEFINITIONS. As used herein, the following definitions shall apply:

            (a) "Applicable Laws" means the legal requirements relating to the
administration of stock option plans under federal and state corporate and
securities laws and the Code.

            (b) "Board" means the Board of Directors of the Company.

            (c) "Code" means the Internal Revenue Code of 1986, as amended.

            (d) "Committee" means a committee appointed by the Board in
accordance with Section 4 of this Plan.

            (e) "Common Stock" means the Common Stock of the Company.

            (f) "Company" means Endocare, Inc., a Delaware corporation.

            (g) "Consultant" means any person, including an advisor, engaged by
the Company or a Parent or Subsidiary to render services in a non-employee
capacity and who is compensated for such services.

            (h) "Continuous Status as an Employee, Consultant or Outside
Director" means that the employment, consulting or director relationship with
the Company, any Parent, or Subsidiary, is not interrupted or terminated.
Continuous Status as an Employee, Consultant or Outside Director shall not be
considered interrupted in the case of (i) any leave of absence approved by the
Company or (ii) transfers between locations of the Company or between the
Company, its Parent, any Subsidiary, or any successor. A leave of absence
approved by the Company shall include sick leave, military leave, or any other
personal leave approved by an authorized representative of the Company.

            (i) "Director" means a member of the Board.

            (j) "Disability" means total and permanent disability as defined in
Code Section 22(e)(3).
<PAGE>
            (k) "Employee" means any person, including Officers and Directors,
employed by the Company or any Parent or Subsidiary of the Company. Neither
service as a Director nor payment of a director's fee by the Company shall be
sufficient to constitute "employment" by the Company.

            (l) "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

            (m) "Fair Market Value" means, as of any date, the value of Common
Stock determined as follows:

                  (i) If the Common Stock is admitted to trading or listed on a
      national securities exchange, Fair Market Value shall be the last reported
      sale price regular way, or if no such reported sale takes place on that
      day, the average of the last reported bid and ask prices regular way, in
      either case on the principal national securities exchange on which the
      Common Stock is admitted to trading or listed.

                  (ii) If not admitted to trading or listed on any national
      securities exchange, Fair Market Value shall be the last sale price on
      that day of the Common Stock reported on the Nasdaq National Market or the
      Nasdaq SmallCap Market ("Nasdaq Stock Market") or, if no such reported
      sale takes place on that day, the average of the closing bid and ask
      prices on that day.

                  (iii) If not included on the Nasdaq Stock Market, Fair Market
      Value shall be the average of the closing bid and ask prices of the Common
      Stock on that day reported by the Nasdaq electronic bulletin board, or any
      comparable system on that day.

                  (iv) If the Common Stock is not included on the Nasdaq
      electronic bulletin board or any comparable system, Fair Market Value
      shall be the closing bid and ask prices on that day as furnished by any
      member of the National Association of Securities Dealers, Inc. selected
      from time to time by the Company for that purpose.

            (n) "Family Member" means the Optionee's children, stepchildren,
grandchildren, parents, stepparents, grandparents, spouse, former spouse,
siblings, nieces, nephews, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law, including adoptive
relationships, a trust in which any of the foregoing individuals have more than
a fifty percent (50%) beneficial interest, a foundation in which any of the
foregoing individuals (or the Optionee) control the management of assets, and
any other entity in which any of the foregoing individuals (or Optionee) own
more than fifty percent (50%) of the voting interests.

            (o) "Nonstatutory Stock Option" means an Option that is not intended
to qualify as an incentive stock option under Code Section 422.

            (p) "Notice of Grant" means a written notice evidencing certain
terms and conditions of an individual Option. The Notice of Grant is part of the
Option Agreement.

                                       2.
<PAGE>
            (q) "Officer" means a person who is an officer of the Company within
the meaning of Section 16 of the Exchange Act and the rules and regulations
promulgated thereunder.

            (r) "Option" means a stock option granted pursuant to the Plan.

            (s) "Option Agreement" means a written agreement between the Company
and an Optionee evidencing the terms and conditions of an individual Option
grant. The Option Agreement is subject to the terms and conditions of this Plan.

            (t) "Optioned Stock" means the Common Stock subject to an Option.

            (u) "Optionee" means an Employee, Consultant or Outside Director who
holds an outstanding Option.

            (v) "Outside Director" means a Director who is not an Employee.

            (w) "Parent" means a "parent corporation," whether now or hereafter
existing, as defined in Section 424( e) of the Code.

            (x) "Plan" means this Endocare, Inc. 2002 Supplemental Stock Plan.

            (y) "Rule 16b-3" means Rule 16b-3 under the Exchange Act or any
successor to Rule 16b-3, as in effect when discretion is being exercised with
respect to the Plan.

            (z) "Section 16(b)" means Section 16(b) of the Exchange Act.

            (aa) "Share" means a share of the Common Stock.

            (bb) "Subsidiary" means a "subsidiary corporation," whether now or
hereafter existing, as defined in Section 424(f) of the Code.

      3. STOCK SUBJECT TO THE PLAN.

            (a) Subject to the provisions of Section 12 of this Plan, the
maximum aggregate number that may be issued under the Plan is four hundred
thirty-five thousand (435,000) Shares. The Shares may be authorized but
unissued, or reacquired Common Stock.

            (b) If an Option expires or becomes unexercisable without having
been exercised in full, the unpurchased Shares which were subject thereto shall
become available for future grant or sale under the Plan (unless the Plan has
terminated).

      4. ADMINISTRATION OF THE PLAN.

            (a) PROCEDURE.

                  (i) Multiple Administrative Bodies. If permitted by Rule
      16b-3, the Plan may be administered by different bodies with respect to
      (A) Directors, Officers who

                                       3.
<PAGE>
      are not Directors, and as to (B) Employees who are neither Directors nor
      Officers as well as Consultants.

                  (ii) Administration With Respect to Directors and Officers
      Subject to Section 16(b). With respect to Option grants made to Employees
      who are also Officers or Directors subject to Section 16(b) of the
      Exchange Act, the Plan shall be administered by (A) the Board, if the
      Board may administer the Plan under Rule 16b-3 or (B) a committee
      designated by the Board to administer the Plan, to the extent possible and
      advisable, the committee shall be constituted to comply with the rules
      under Rule 16b-3. Once appointed, such Committee shall continue to serve
      in its designated capacity until otherwise directed by the Board. The
      Board may increase the size of the Committee and appoint additional
      members, remove members (with or without cause) and substitute new
      members, fill vacancies (however caused), and remove all members of the
      Committee and thereafter directly administer the Plan. Additionally, to
      the extent possible and advisable, the Committee shall be composed of
      "Outside Directors" as that term is used in Section 162(m) of the Code.

            (b) ADMINISTRATION WITH RESPECT TO OTHER PERSONS. With respect to
Option grants made to Employees or Consultants who are neither Directors nor
officers of the Company, the Plan shall be administered by (A) the Board or (B)
a committee designated by the Board, which committee shall be constituted to
satisfy Applicable Laws. Once appointed, such Committee shall serve in its
designated capacity until otherwise directed by the Board. The Board may
increase the size of the Committee and appoint additional members, remove
members (with or without cause) and substitute new members, fill vacancies
(however caused), and remove all members of the Committee and thereafter
directly administer the Plan, all to the extent permitted by Applicable Laws.

            (c) POWERS OF THE COMMITTEE. Subject to the provisions of this Plan,
and in the case of a Committee, subject to the specific duties delegated by the
Board to such Committee, the Committee shall have the authority, in its
discretion to:

                  (i) Determine the Fair Market Value of the Common Stock in
      accordance with Section 2(m) of this Plan;

                  (ii) Select the Employees, Consultants and Outside Directors
      to whom Options may be granted hereunder;

                  (iii) Determine whether and to what extent Options are granted
      hereunder;

                  (iv) Determine the number of shares of Common Stock to be
      covered by each Option granted hereunder;

                  (v) Approve forms of agreement for use under the Plan;

                  (vi) Determine the terms and conditions, not inconsistent with
      the terms of the Plan, of any award granted hereunder. Such terms and
      conditions include,

                                       4.
<PAGE>
      but are not limited to, the exercise price, the time or times when Options
      may be exercised (which may be based on performance criteria), any vesting
      acceleration or waiver of forfeiture restrictions, and any restriction or
      limitation regarding any Option or the shares of Common Stock relating
      thereto, based in each case on such factors as the Committee, in its sole
      discretion, shall determine;

                  (vii) Construe and interpret the terms of the Plan and awards
      granted pursuant to the Plan;

                  (viii) Prescribe, amend and rescind rules and procedures
      relating to the Plan;

                  (ix) Modify or amend each Option (subject to the limits of
      Section 15 of this Plan), including the discretionary authority to extend
      the post-termination exercisability period of Options longer than is
      otherwise provided for in the Plan;

                  (x) Authorize any person to execute on behalf of the Company
      the Notice of Grant;

                  (xi) Determine the terms and restrictions applicable to
      Options; and

                  (xii) Take all other actions deemed necessary or advisable for
      administering the Plan.

            (d) EFFECT OF COMMITTEE'S DECISION. The Committee's decisions,
determinations and interpretations shall be final and binding on all Optionees
and any other holders of Options.

      5. ELIGIBILITY.Nonstatutory Stock Options may be granted to Employees,
Consultants and Outside Directors. If otherwise eligible, an Employee,
Consultant or Outside Director who has been granted an Option may be granted
additional Options.

      6. LIMITATIONS.

            (a) Each Option shall be designated in the written option agreement
as a Nonstatutory Stock Option.

            (b) Neither the Plan nor any Option shall confer upon an Optionee
any right with respect to continuing the Optionee's employment, consulting or
director relationship with the Company, nor shall they interfere in any way with
the Optionee's right or the Company's right to terminate such employment,
consulting or director relationship at any time, with or without cause.

            (c) In the event that the date of grant of an Option is not a
trading day, the exercise price per Share shall be the Fair Market Value on the
next trading day immediately following the date of grant of the Option.

                                       5.
<PAGE>
      7. TERM OF PLAN. The Plan became effective on June 25, 2002. It shall
continue in effect for a term often (10) years (June 24, 2012) unless terminated
earlier under Section 15 of this Plan.

      8. TERM OF OPTION. The term of each Option shall be stated in the Notice
of Grant.

      9. OPTION EXERCISE PRICE AND CONSIDERATION.

            (a) EXERCISE PRICE. The per Share exercise price for the Shares to
be issued pursuant to exercise of an Option shall be determined by the Board,
but shall not be less than eighty-five percent (85%) of the Fair Market Value
per Share on the date of grant.

            (b) WAITING: PERIOD AND EXERCISE DATES. At the time an Option is
granted, the Committee shall fix the period within which the Option may be
exercised and shall determine any conditions which must be satisfied before the
Option may be exercised. In so doing, the Committee may specify that an Option
may not be exercised until the completion of a service period.

            (c) FORM OF CONSIDERATION. The Committee shall determine the
acceptable form of consideration for exercising an Option, including the method
of payment. Such consideration may consist of:

                  (i) Cash;

                  (ii) Check;

                  (iii) Promissory note;

                  (iv) Other Shares which (A) have been owned by the Optionee
      for more than six months on the date of surrender and (B) have a Fair
      Market Value on the date of surrender equal to the aggregate exercise
      price of the Shares as to which said Option shall be exercised;

                  (v) Delivery of exercise form together with irrevocable
      instructions to a broker-dealer to sell a sufficient portion of the shares
      of Common Stock and to deliver the sale loan proceeds directly to the
      Company to pay all or a portion of the exercise price of the Option and/or
      any income tax withholding obligations;

                  (vi) Any combination of the foregoing methods of payment; or

                  (vii) Such other consideration and method of payment for the
      issuance of Shares selected by the Board of Directors that is permissible
      under Applicable Law.

      10. EXERCISE OF OPTION.

                                       6.
<PAGE>
            (a) PROCEDURE FOR EXERCISE; RIGHTS AS A STOCKHOLDER. Any Option
granted hereunder shall be exercisable according to the terms of the Plan and at
such times and under such conditions as determined by the Committee and set
forth in the Option Agreement.

            (b) An Option may not be exercised for a fraction of a Share.

            (c) An Option shall be deemed exercised when the Company receives
(i) written notice of exercise (in accordance with the Option Agreement) from
the person entitled to exercise the Option, and (ii) full payment for the Shares
with respect to which the Option is exercised. Full payment may consist of any
consideration and method of payment authorized by the Committee and permitted by
the Option Agreement and the Plan. Shares issued upon exercise of an Option
shall be issued in the name of the Optionee or, if requested by the Optionee, in
the name of the Optionee and his or her spouse. Until the stock certificate
evidencing such Shares is issued (as evidenced by the appropriate entry on the
books of the Company or of a duly authorized transfer agent of the Company), no
right to vote or receive dividends or any other rights as a stockholder shall
exist with respect to the Optioned Stock, notwithstanding the exercise of the
Option. The Company shall issue (or cause to be issued) such stock certificate
promptly after the Option is exercised. No adjustment will be made for a
dividend or other right for which the record date is prior to the date the stock
certificate is issued.

            (d) Exercising an Option in any manner shall decrease the number of
Shares thereafter available, both for purposes of the Plan and for sale under
the Option, by the number of Shares as to which the Option is exercised.

            (e) TERMINATION OF EMPLOYMENT, CONSULTING OR DIRECTOR RELATIONSHIP.
Upon termination of an Optionee's Continuous Status as an Employee, Consultant
or Director, other than upon the Optionee's death or Disability, the Optionee
may exercise his or her Option, but only within such period of time as is
specified in the Notice of Grant, and only to the extent that the Optionee was
entitled to exercise it at the date of termination (but in no event later than
the expiration of the term of such Option as set forth in the Notice of Grant).
In the absence of a specified time in the Notice of Grant, the Option shall
remain exercisable for three (3) months following the Optionee's termination.
If, on the date of termination, the Optionee is not entitled to exercise the
Option for all the Shares, then the Option shall immediately terminate with
respect to the Shares covered by the unexercisable portion of such Option, and
those Shares shall immediately revert to the Plan. If, after the date of
Optionee's termination, the Optionee does not, within the time specified in the
Option, exercise his or her Option for all the Shares for which that Option is
exercisable on such termination date, then the Option shall terminate with
respect to those remaining Shares, and such Shares shall revert to the Plan.

            (f) Notwithstanding the above, in the event of an Optionee's change
in status from Consultant, Employee or Outside Director to another
classification, an Optionee's Continuous Status as an Employee, Consultant or
Outside Director shall not automatically terminate solely as a result of such
change in status.

            (g) DISABILITY OF OPTIONEE. In the event that an Optionee's
Continuous Status as an Employee, Consultant or Outside Director terminates as a
result of the Optionee's Disability, the Optionee may exercise his or her Option
at any time within twelve (12) months from the date

                                       7.
<PAGE>
of such termination, but only to the extent that the Optionee was entitled to
exercise it at the date of such termination (but in no event later than the
expiration of the term of such Option as set forth in the Notice of Grant). If,
the Optionee is not entitled to exercise the Option for all the Shares, then the
Option shall immediately terminate with respect to the Shares covered by the
unexercisable portion of such Option, and those Shares shall immediately revert
to the Plan. If, after the date of Optionee's termination, the Optionee does
not, within the time specified in the Option, exercise his or her Option for all
the Shares for which that Option is exercisable on such termination date, then
the Option shall terminate with respect to those remaining Shares, and such
Shares shall revert to the Plan.

            (h) DEATH OF OPTIONEE. In the event of the death of an Optionee, the
Option may be exercised at any time within twelve (12) months following the date
of death (but in no event later than the expiration of the term of such Option
as set forth in the Notice of Grant), by the Optionee's estate nor by a person
who acquired the right to exercise the Option by bequest or inheritance, but
only to the extent that the Optionee was entitled to exercise the Option at the
date of death. If, at the time of death, the Optionee was not entitled to
exercise the Option for all the Shares, then the Option shall immediately
terminate with respect to the Shares covered by the unexercisable portion of
such Option, and those Shares shall immediately revert to the Plan. If, after
Optionee's death, the Optionee's estate or a person who acquired the right to
exercise the Option by bequest or inheritance does not, within the time
specified in the Option, exercise the Option for all the Shares for which that
Option is exercisable on the date of Optionee's death, then the Option shall
terminate with respect to those remaining Shares, and such Shares shall revert
to the Plan.

      11. LIMITED TRANSFERABILITY OF OPTIONS. During the lifetime of the
Optionee, Nonstatutory Options shall be exercisable only by the Optionee and
shall not be assignable or transferable other than by will or by the laws of
descent and distribution following the Optionee's death. A Nonstatutory Option
may, in connection with the Optionee's estate plan, be assigned in whole or in
part during the Optionee's lifetime to one or more Family Members of the
Optionee or to a trust established exclusively for one or more such Family
Members. The assigned portion may only be exercised by the person or persons who
acquire a proprietary interest in the option pursuant to the assignment. The
terms applicable to the assigned portion shall be the same as those in effect
for the option immediately prior to such assignment and shall be set forth in
such documents issued to the assignee as the Committee may deem appropriate.

      12. ADJUSTMENTS.

            (a) In the event of any change in the capitalization of the Company
affecting its Common Stock (e.g., a stock split, reverse stock split, stock
dividend, recapitalization, combination, or reclassification), there shall be an
adjustment to:

                  (i) The maximum number and/or kind of Shares that may be
      granted under this Plan;

                  (ii) The number and/or kind of Shares covered by each
      outstanding Option; and

                                       8.
<PAGE>
                  (iii) The exercise price per Share in respect of each
      outstanding Option.

            (b) The Committee may also make such adjustments in the event of a
spin-off or other distribution of Company assets to stockholders (other than
normal cash dividends).

      13. EXTRAORDINARY EVENTS.

            (a) The Plan as well as each outstanding Option shall terminate upon
the occurrence of any of the following events ("Extraordinary Events"):

                  (i) The dissolution, liquidation, or sale of all (or
      substantially all) of the assets of the Company;

                  (ii) Any reorganization, merger, or consolidation in which the
      Company does not survive;

                  (iii) The acquisition by any person or group (as defined in
      Section 13D of the Exchange Act) of beneficial ownership of more than
      fifty percent (50%) of the Company Stock; or

                  (iv) Any reorganization, merger, or consolidation in which the
      Company does survive but the Shares outstanding immediately preceding the
      transaction are converted by virtue of the transaction into other
      property, whether in the form of securities, cash, or otherwise. However,
      in no case will an Extraordinary Event be deemed to have occurred as a
      result of a sale of stock to the Company or to a holding company
      established by the Company.

            (b) If an Extraordinary Event occurs, all Options shall become fully
exercisable. Each Participant shall have the right to exercise any unexpired
Option(s) prior to the Extraordinary Event. However, the effectiveness of any
such exercise shall be:

                  (i) Conditioned upon:

                        (A) The Extraordinary Event actually occurring; and

                        (B) The Committee's receipt of the notice of exercise
      within the time period established by the Committee; and

                  (ii) Delayed until immediately prior to the Extraordinary
      Event.

      14. DATE OF GRANT. The date of grant of an Option shall be, for all
purposes, the date on which the Committee makes the determination granting such
Option, or such other later date as is determined by the Committee. The Notice
of Grant shall be provided to each Optionee within a reasonable time after the
date of such grant.

      15. AMENDMENT AND TERMINATION.

                                       9.
<PAGE>
            (a) AMENDMENT AND TERMINATION. The Board may at any time amend,
alter, suspend or terminate the Plan.

            (b) EFFECT OF AMENDMENT OR TERMINATION. No amendment, alteration,
suspension or termination of the Plan or Option shall impair the rights of any
Optionee, unless mutually agreed otherwise between the Optionee and the
Committee.

      16. CONDITIONS UPON ISSUANCE OF SHARES.

            (a) LEGAL COMPLIANCE. Shares shall not be issued pursuant to the
exercise of an Option unless the exercise of such Option and the issuance and
delivery of such Shares shall comply with all relevant provisions of law,
including, without limitation, the Securities Act of 1933, as amended, the
Exchange Act as well as the rules and regulations promulgated thereunder,
Applicable Laws, and the requirements of any stock exchange or quotation system
upon which the Shares may then be listed or quoted, and shall be further subject
to the approval of counsel for the Company with respect to such compliance.

            (b) INVESTMENT REPRESENTATIONS. As a condition to the exercise of an
Option, the Company may require the person exercising such Option to represent
and warrant at the time of any such exercise that the Shares are being purchased
only for investment and without any present intention to sell or distribute such
Shares if, in the opinion of counsel for the Company, such a representation is
required.

      17. LIABILITY OF COMPANY.

            (a) INABILITY TO OBTAIN AUTHORITY. The inability of the Company to
obtain authority from any regulatory body having jurisdiction, which authority
is deemed by the Company's counsel to be necessary to the lawful issuance and
sale of any Shares hereunder, shall relieve the Company of any liability in
respect of the failure to issue or sell such Shares as to which such requisite
authority shall not have been obtained.

            (b) GRANTS EXCEEDING: ALLOTTED SHARES. If the Optioned Stock covered
by an Option exceeds, as of the date of grant, the number of Shares which may be
issued under the Plan without additional stockholder approval, such Option shall
be void with respect to such excess Optioned Stock, unless stockholder approval
of an amendment sufficiently increasing the number of Shares subject to the Plan
is timely obtained.

      18. RESERVATION OF SHARES. The Company, during the term of this Plan, will
at all times reserve and keep available such number of Shares as shall be
sufficient to satisfy the requirements of the Plan.

                                      10.<PAGE>

                                                                   EXHIBIT 10.29

                              EMPLOYMENT AGREEMENT

        Endocare, Inc. ("Endocare"), with its principal offices located at 7
Studebaker, Irvine, CA 92618, and Holly Williams (hereinafter "Williams") agree
as follows:

        The parties hereto acknowledge that Williams has been employed by
Endocare since August 14, 2000. In consideration of Endocare's agreement to
continue employing Williams pursuant to the terms of this written Employment
Agreement (the "Agreement"), Williams' promise to continue working for Endocare
pursuant to the terms of this Agreement and the other mutual promises contained
herein, the parties voluntarily agree as follows:

        1. EFFECTIVE DATE: The provisions of this Agreement shall be effective
beginning May 1, 2002 (the "Effective Date").

        2. TERM AND NATURE OF EMPLOYMENT:

           (a) Services. Pursuant to the terms of this Agreement, Williams
agrees to provide in-house counseling services ("Services") to Endocare.

           (b) Part-Time Employment; Hours Requirements. From May 1, 2002, until
September 30, 2002, inclusive (the "First Period"), Williams shall provide
Services to Endocare on a schedule representing eighty percent (80%) of a
full-time employment schedule, or thirty-two (32) hours per week.

           From October 1, 2002, until April 30, 2003, inclusive (the "Second
Period"), Williams shall provide Services to Endocare on a schedule representing
twenty percent (20%) of a full-time employment schedule, or eight (8) hours per
week.

           (c) Compensation. Williams shall receive a semi-monthly salary,
payable on the fifteenth (15th) and last days of each month. Williams'
semi-monthly salary during the First Period shall be $4,000.00 less applicable
withholding taxes. Williams' semi-monthly salary during the Second Period shall
be $1,000.00 less applicable withholding taxes.

           In the event that Williams shall provide Services in excess of
thirty-two (32) hours in a single workweek during the First Period of her
employment, or in excess of eight (8) hours in a single workweek during the
Second Period of her employment, she shall be compensated at an hourly rate of
fifty-eight dollars ($58) for each such hour worked in excess of the hours
requirements described in Paragraph 2(b) of this Agreement.

           Compensation will be paid in accordance with Endocare's standard
payroll procedures and practices.

           (d) Business Expenses. Upon presentation of appropriate
documentation, Endocare shall reimburse Williams for reasonable, out-of-pocket
business expenses incurred by Williams in the course of her provision of
Services under this Agreement. Williams will submit monthly expense reports for
approval by the Board of Directors or Chief Financial Officer of Endocare.

<PAGE>

           (e) Stock Options. On December 28, 2000, Williams was granted an
incentive stock option to purchase up to Twenty Thousand (20,000) shares of
Endocare's Common Stock at $12.4375 per share; on January 1, 2001, Williams was
granted an incentive stock option to purchase up to Fifteen Thousand Four
Hundred Eleven (15,411) shares of Endocare's Common Stock at $5.1200 per share;
on January 1, 2001, Williams was granted a nonqualified stock option to purchase
up to Twenty Nine Thousand Five Hundred Eighty Nine (29,589) shares of
Endocare's Common Stock at $5.1200 per share; and on July 19, 2001, Williams was
granted a nonqualified stock option to purchase up to Twenty Thousand (20,000)
shares of Endocare's Common Stock at $17.6400 per share (collectively, the
"Options"). As of the Effective Date, Williams had acquired a vested interest in
Twenty Thousand Three Hundred Thirteen shares under the Options, and had
exercised her right under the Option to purchase no shares of Endocare's Common
Stock. Williams' interest under the Options shall continue to vest in accordance
with Endocare's 1995 Stock Plan, as amended, and Williams' individual Stock
Option Agreements thereunder, throughout the term of Williams' employment by
Endocare under this Agreement.

           (f) Facilities. Endocare shall not provide Williams with facilities
or office space during Williams' employment by Endocare under this Agreement.

        3. TERMINATION: Williams' employment under this Agreement may only be
terminated by Endocare solely upon the occurrence of any of the following:

           (a) Williams' commission of any act of fraud with respect to Endocare
or Endocare's business.

           (b) Williams' conviction of or being formally charged with the
commission of any felony; or

           (c) Williams' conviction of or being formally charged with the
commission of any crime which, in the good faith judgement of Endocare's Board
of Directors, involved moral turpitude and has caused or will cause material
harm to Endocare's standing and/or reputation.

        4. GENERAL MUTUAL RELEASE: The parties, including their heirs,
executors, administrators, assigns, successors and current, former and future
parents, subsidiaries, related entities, employee benefit plans and their
fiduciaries, predecessors, successors, officers, directors, shareholders, agents
and employees, if any, fully and forever release and discharge one another with
respect to any and all claims, liabilities and causes of action, of every
nature, kind and description, in law, equity or otherwise, which have arisen,
occurred or existed at any time prior to the Effective Date of this Agreement,
including, without limitation, any and all claims, liabilities and causes of
action arising out of or relating to Williams' employment with Endocare or the
cessation of that employment.

        5. KNOWING WAIVER OF EMPLOYMENT-RELATED CLAIMS: Williams understands and
agrees that, with the exception of potential employment-related claims
identified below, she is waiving any and all rights she may have had, now has,
or in the future may have, to pursue against Endocare or any of its current,
former and future parents, subsidiaries, related entities, employee benefit
plans and their fiduciaries, predecessors, successors, officers, directors,

                                      -2-
<PAGE>

shareholders, agents, employees and assigns, any and all remedies available to
her under any employment-related causes of action, including without limitation,
claims of wrongful discharge, breach of contract, breach of the covenant of good
faith and fair dealing, fraud, violation of public policy, defamation,
discrimination, personal injury, physical injury, emotional distress, claims
under Title VII of the Civil Rights Act of 1964, as amended, the Americans With
Disabilities Act, the Age Discrimination in Employment Act, the Federal
Rehabilitation Act, the Family and Medical Leave Act, the California Fair
Employment and Housing Act, the California Family Rights Act, the Equal Pay Act
of 1963, the provisions of the California Labor Code and any other federal,
state or local laws and regulations relating to employment, conditions of
employment (including wage and hour laws) and/or employment discrimination.
Claims not covered by the release provisions of this Agreement are (i) claims
for unemployment insurance benefits, and (ii) claims under the California
Workers' Compensation Act.

        6. WAIVER OF CIVIL CODE SECTION 1542. Each party expressly waives any
and all rights and benefits conferred upon such party by Section 1542 of the
Civil Code of the State of California, which states as follows:

           "A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES
           NOT KNOW OR SUSPECT TO EXIST IN HER FAVOR AT THE TIME OF EXECUTING
           THE RELEASE, WHICH IF KNOWN BY HER MUST HAVE MATERIALLY AFFECTED HER
           SETTLEMENT WITH THE DEBTOR."

           Each party expressly agrees and understands that the release given in
Paragraph 4 of this Agreement applies to all unknown, unsuspected and
unanticipated claims, liabilities and causes of action which such party may have
against the other party.

        7. BENEFITS: Williams shall be entitled to participate in the health
care plan provided by Endocare to its employees, on the same terms and
conditions as other participating employees, from the Effective Date through
June 30, 2002.

           Commencing July 1, 2002, Williams shall not be entitled to
participate in the health care plan provided by Endocare to its employees.

           Williams acknowledges and understands that the health care benefits
provided by Endocare may be changed or terminated at any time in Endocare's sole
discretion.

           Endocare acknowledges that Williams is entitled to participate in
Endocare's calendar year 2001 401(k) plan and other calendar year 2001 benefit
programs of Endocare under the terms and conditions of such plan or programs, as
may be amended by the Board of Directors of Endocare from time to time.

        8. BONUSES: Williams acknowledges and understands that she will not be
eligible for any bonus for her Services during either the First Period or Second
Period of her employment pursuant to this Agreement. Williams further
acknowledges and understands that she is not currently eligible for any bonus
for services she has already provided to Endocare.

                                      -3-
<PAGE>

        9. CONFIDENTIALITY: The parties acknowledge and agree that the
identities of Endocare's customers and potential customers is confidential,
trade secret information. In the event Williams's employment with Endocare
terminates for any reason whatsoever, Williams agrees that for one year from the
date of said termination, she will not directly or indirectly, as principal,
agent, owner, employee, officer, director, shareholder or otherwise, contact any
of Endocare's customers or prospects for the purpose of attempting to provide
such persons or entities with services offered by Endocare, or for the purpose
of selling or soliciting the sale of marketing research or consulting services
to said customers or prospects.

        10. NON-DISPARAGEMENT. Williams shall not at any time after the date
hereof disparage Endocare or it's officers, directors, employees or agents.
Similarly, Endocare and its officers, directors, employees and agents shall not
disparage Williams.

        11. TERMS OF AGREEMENT. Both Williams and the Company agree that the
terms and conditions of this Agreement are confidential shall not be disclosed
to any third-party by either party to this Agreement without written consent of
the other party. The obligations under this Section 11 shall not apply to
disclosures required by applicable law, regulation or order or court or
governmental agency, or disclosure to either party's attorneys or accountants.

        12. ENTIRE AGREEMENT: This Agreement supersedes any and all other
agreements, either oral or in writing, between the parties hereto with respect
to the employment of Williams by Endocare and contains all of the covenants and
agreements between the parties with respect to that employment. The parties
acknowledge and agree that no other representations, inducements, promises or
agreements have been made by any party, and that this Agreement reflects the
entire agreement between them. The parties further agree that this Agreement may
be changed only in a writing signed by both parties.

                                            ENDOCARE, INC.

        Dated:  6/5/02                      /s/ JOHN CRACCHIOLO
               ---------------              ------------------------------------

        Dated:  6/5/02                      /s/ HOLLY WILLIAMS
               ---------------              ------------------------------------
                                            Holly Williams

                                      -4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}]]